Ocera Therapeutics
Biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Launch date
Market cap
-
Enterprise valuation
$42m (Public information from Nov 2017)
Palo Alto California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$12.0m | Series B | ||
$35.5m | Series C | ||
N/A | N/A | IPO | |
N/A | $1.5m | Debt | |
$28.0m | Post IPO Equity | ||
$20.0m | Post IPO Debt | ||
$42.0m Valuation: $42.0m | Acquisition | ||
Total Funding | $47.5m |
Related Content
Recent News about Ocera Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.